ClinicalTrials.gov
public full text
Public Domain
JSKN022 in Subjects With Advanced Malignant Solid Tumors
The goal of this clinical trial is to learn if drug JSKN022 is safe to treat patients with advanced malignant solid tumors. It will also learn about the pharmacokinetic/ pharmacodynamic profiles and preliminary antitumor activity of drug JSKN022.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma#1164439
- A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour#1114066
- Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors#805562
- A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors#1172637
- A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors#803989
Record · ID 855285
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive